Insulin-like growth-factor-1-induced PKB signaling and Egr-1 expression is inhibited by curcumin in A-10 vascular smooth muscle cells

Canadian Journal of Physiology and Pharmacology

Volumn 91, Issue 3, 2013, Pages 241-247

  Youreva, Viktoria ^a,b   Kapakos, Georgia ^a,b   Srivastava, Ashok K ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Curcumin; Early growth response protein 1; Glycogen synthase kinase 3 ; Insulin like growth factor 1; Protein kinase B; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN II; CURCUMIN; EARLY GROWTH RESPONSE FACTOR 1; ENDOTHELIN 1; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN KINASE B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ARTICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL LINE; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EARLY GROWTH RESPONSE PROTEIN 1; ENZYME INDUCTION; GENE EXPRESSION REGULATION; INSULIN-LIKE GROWTH FACTOR I; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION;

EID: 84875495538     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2012-0267     Document Type: Article

References (75)

1. Ak, T., and Gulcin, I. 2008. Antioxidant and radical scavenging properties of curcumin. Chem. Biol. Interact. 174: 27-37. doi:10.1016/j.cbi.2008.05.003. m18547552.
2. Anand, P., Sung, B., Kunnumakkara, A.B., Rajasekharan, K.N., and Aggarwal, B.B. 2011 Suppression of pro-inflammatory and proliferative pathways by diferuloylmethane (curcumin) and its analogues dibenzoylmethane, dibenzoylpropane, and dibenzylideneacetone: role of Michael acceptors and Michael donors. Biochem. Pharmacol. 82: 1901-1909. doi:10.1016/j.bcp.2011.09. 001. PMID:21924245.
3. Azar, Z.M., Mehdi, M.Z., and Srivastava, A.K. 2006. Activation of insulin-like growth factor type-1 receptor is required for H2O2-induced PKB phosphorylation in vascular smooth muscle cells. Can. J. Physiol. Pharmacol. 84: 777-786. doi:10.1139/y06-024. PMID:16998541.
4. Bayes-Genis, A., Conover, C.A., and Schwartz, R.S. 2000. The insulin-like growth factor axis: A review of atherosclerosis and restenosis. Circ. Res. 86: 125-130. doi:10.1161/01.RES.86.2.125. PMID:10666406.
5. Beevers, C.S., Li, F., Liu, L., and Huang, S. 2006. Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells. Int. J. Cancer, 119: 757-764. doi:10.1002/ijc.21932. PMID:16550606.
6. Beevers, C.S., Chen, L., Liu, L., Luo, Y., Webster, N.J., and Huang, S. 2009. Curcumin disrupts the Mammalian target of rapamycin-raptor complex. Cancer Res. 69: 1000-1008. doi:10.1158/0008-5472.CAN-08-2367. PMID:19176385.
7. Blaschke, F., Bruemmer, D., and Law, R.E. 2004. Egr-1 is a major vascular pathogenic transcription factor in atherosclerosis and restenosis. Rev. Endocr. Metab. Disord. 5: 249-254. doi:10.1023/B:REMD.0000032413.88756.ee. PMID: 15211096.
8. Bonnet, S., Paulin, R., Sutendra, G., Dromparis, P., Roy, M., Watson, K.O., et al. 2009. Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-{beta}/NFAT axis. Circulation, 120: 1231-1240. doi:10.1161/CIRCULATIONAHA.109.848911. PMID:19752325.
9. Bouallegue, A., Daou, G.B., and Srivastava, A.K. 2007a. Endothelin-1-inducedsignaling pathways in vascular smooth muscle cells. Curr. Vasc. Pharmacol. 5: 45-52. doi:10.2174/157016107779317161. PMID:17266612.
10. Bouallegue, A., Daou, G.B., and Srivastava, A.K. 2007b. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway. Am. J. Physiol. Heart Circ. Physiol. 293: H2072-H2079. doi:10.1152/ajpheart.01097.2006. PMID:17644565.
11. Bouallegue, A., Vardatsikos, G., and Srivastava, A.K. 2009. Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1-and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells. Can. J. Physiol. Pharmacol. 87: 1009-1018. doi:10.1139/Y09-056. PMID:20029537.
12. Bouallegue, A., Vardatsikos, G., and Srivastava, A.K. 2010. Involvement of insulin-like growth factor 1 receptor transactivation in endothelin-1-induced signaling in vascular smooth muscle cells. Can. J. Physiol. Pharmacol. 88: 501-509. doi:10.1139/Y10-030. PMID:20555420.
13. Cheng, A.L., Hsu, C.H., Lin, J.K., Hsu, M.M., Ho, Y.F., Shen, T.S., et al. 2001. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 21: 2895-2900. PMID:11712783.
14. Chen, A., Xu, J., and Johnson, A.C. 2006. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene, 25: 278-287. doi:10.1038/sj.onc.1209019. PMID:16170359.
15. 2+-dependent Egr-1 expression and subsequently inhibits vascular smooth muscle cell proliferation induced by angiotensin II. Cell Physiol. Biochem. 23: 295-304. doi:10.1159/ 000218176. PMID:19471097.
16. Choi, B.H., Kim, C.G., Bae, Y.S., Lim, Y., Lee, Y.H., and Shin, S.Y. 2008. p21 Waf1/ Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression. Cancer Res. 68: 1369-1377. doi:10.1158/0008-5472.CAN-07-5222. PMID:18316600.
17. Clemmons, D.R. 2007. Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer. Nat. Rev. Drug Discov. 6: 821-833. doi:10.1038/nrd2359. PMID:17906644.
18. Delafontaine, P. 1995. Insulin-like growth factor I and its binding proteins in the cardiovascular system. Cardiovasc. Res. 30: 825-834. doi:10.1016/S0008-6363(95)00163-8. PMID:8746194.
19. Delafontaine, P., Song, Y.H., and Li, Y. 2004. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler. Thromb. Vasc. Biol. 24: 435-444. doi:10.1161/01.ATV.0000105902.89459.09. PMID:14604834.
20. Doble, B.W., and Woodgett, J.R. 2003. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116: 1175-1186. doi:10.1242/jcs.00384. PMID:12615961.
21. Fahmy, R.G., and Khachigian, L.M. 2007. Suppression of growth factor expression and human vascular smooth muscle cell growth by small interfering RNA targeting EGR-1. J. Cell. Biochem. 100: 1526-1535. doi:10.1002/jcb.21145. PMID:17171647.
22. Gao, J., Zhou, H., Lei, T., Zhou, L., Li, W., Li, X., and Yang, B. 2011. Curcumin inhibits renal cyst formation and enlargement in vitro by regulating intracellular signaling pathways. Eur. J. Pharmacol. 654: 92-99. doi:10.1016/j.ejphar. 2010.12.008. PMID:21187084.
23. Ghosh, S.S., Salloum, F.N., Abbate, A., Krieg, R., Sica, D.A., Gehr, T.W., and Kukreja, R.C. 2010. Curcumin prevents cardiac remodeling secondary to chronic renal failure through deactivation of hypertrophic signaling in rats. Am. J. Physiol. Heart Circ. Physiol. 299: H975-H984. doi:10.1152/ajpheart. 00154.2010. PMID:20601462.
24. Gomez Sandoval, Y.H., and Anand-Srivastava, M.B. 2011. Enhanced levels of endogenous endothelin-1 contribute to the over expression of Gi{alpha} protein in vascular smooth muscle cells from SHR: Role of growth factor receptor activation. Cell. Signal. 23: 354-362. doi:10.1016/j.cellsig.2010.10.005. PMID: 20959139.
25. Guha, S., Cullen, J.P., Morrow, D., Colombo, A., Lally, C., Walls, D., et al. 2011. Glycogen synthase kinase 3 beta positively regulates Notch signaling in vascular smooth muscle cells: role in cell proliferation and survival. Basic Res. Cardiol. 106: 773-785. doi:10.1007/s00395-011-0189-5. PMID:21557011.
26. Gupta, S.C., Patchva, S., Koh, W., and Aggarwal, B.B. 2012. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin. Exp. Pharmacol. Physiol. 39: 283-299. doi:10.1111/j.1440-1681.2011.05648.x. PMID: 22118895.
27. Han, W., and Liu, G.N. 2010. EGR-1 decoy ODNs inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of balloon-injured arteries in rat. Life Sci. 86: 234-243. doi:10.1016/j.lfs.2009.12.005. PMID:20025889.
28. Harja, E., Bucciarelli, L.G., Lu, Y., Stern, D.M., Zou, Y.S., Schmidt, A.M., and Yan, S.F. 2004. Early growth response-1 promotes atherogenesis: mice deficient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation. Circ. Res. 94: 333-339. doi:10.1161/01. RES.0000112405.61577.95. PMID:14670837.
29. Higashi, Y., Sukhanov, S., Anwar, A., Shai, S.Y., and Delafontaine, P. 2012. Aging, atherosclerosis, and IGF-1. J. Gerontol. A Biol. Sci. Med. Sci. 67: 626-639. doi:10.1093/gerona/gls102. PMID:22491965.
30. Hixon, M.L., Muro-Cacho, C., Wagner, M.W., Obejero-Paz, C., Millie, E., Fujio, Y., et al. 2000. Akt1/PKB upregulation leads to vascular smooth muscle cell hypertrophy and polyploidization. J. Clin. Invest. 106: 1011-1020. doi:10.1172/ JCI8252. PMID:11032861.
31. Hsieh, T., Gordon, R.E., Clemmons, D.R., Busby, W.H., Jr., and Duan, C. 2003. Regulation of vascular smooth muscle cell responses to insulin-like growth factor (IGF)-I by local IGF-binding proteins. J. Biol. Chem. 278: 42886-42892. doi:10.1074/jbc.M303835200. PMID:12917428.
32. Hu, Y.H., Huang, X.R., Qi, M.X., and Hou, B.Y. 2012. Curcumin inhibits proliferation of human lens epithelial cells: a proteomic analysis. J. Zhejiang Univ. Sci. B, 13: 402-407. doi:10.1631/jzus.B1100278. PMID:22556179.
33. Huang, H.C., Jan, T.R., and Yeh, S.F. 1992. Inhibitory effect of curcumin, an anti-inflammatory agent, on vascular smooth muscle cell proliferation. Eur. J. Pharmacol. 221: 381-384. doi:10.1016/0014-2999(92)90727-L. PMID:1426014.
34. Jackson, C.L., and Schwartz, S.M. 1992. Pharmacology of smooth muscle cell replication. Hypertension, 20: 713-736. doi:10.1161/01.HYP.20.6.713. PMID: 1452288.
35. Jia, G., Mitra, A.K., Gangahar, D.M., and Agrawal, D.K. 2010. Insulin-like growth factor-1 induces phosphorylation of PI3K-Akt/PKB to potentiate proliferation of smooth muscle cells in human saphenous vein. Exp. Mol. Pathol. 89: 20-26. doi:10.1016/j.yexmp.2010.04.002. PMID:20471974.
36. Jia, G., Aggarwal, A., Yohannes, A., Gangahar, D.M., and Agrawal, D.K. 2011. Cross-talk between angiotensin II and IGF-1-induced connexin 43 expression in human saphenous vein smooth muscle cells. J. Cell. Mol. Med. 15: 1695-1702. doi:10.1111/j.1582-4934.2010.01161.x. PMID:20731749.
37. Jurenka, J.S. 2009. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern. Med. Rev. 14: 141-153. PMID:19594223.
38. Kang, B.Y., Khan, J.A., Ryu, S., Shekhar, R., Seung, K.B., and Mehta, J.L. 2010. Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition. J. Cardiovasc. Pharmacol. 55: 176-183. doi:10.1097/FJC. 0b013e3181ca4ba1. PMID:19935077.
39. Kapakos, G., Youreva, V., and Srivastava, A.K. 2012a. Cardiovascular protection by curcumin: molecular aspects. Indian J. Biochem. Biophys. 49: 306-315.
40. Kapakos, G., Youreva, V., and Srivastava, A.K. 2012b. Attenuation of endothelin-1-induced PKB and ERK1/2 signaling, as well as Egr-1 expression, by curcumin in A-10 vascular smooth muscle cells. Can. J. Physiol. Pharmacol. 90: 1277-1285. doi:10.1139/y2012-059. PMID:22913328.
41. Khachigian, L.M. 2006. Early growth response-1 in cardiovascular pathobiology. Circ. Res. 98: 186-191. doi:10.1161/01.RES.0000200177.53882.c3. PMID: 16456111.
42. Khachigian, L.M., Lindner, V., Williams, A.J., and Collins, T. 1996. Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science, 271: 1427-1431. doi:10.1126/science.271.5254.1427. PMID:8596917.
43. Kim, S.J., and Hellerstein, M.K. 2007. Pharmacological doses of dietary curcumin increase colon epithelial cell proliferation in vivo in rats. Phytother. Res. 21: 995-998. doi:10.1002/ptr.2053. PMID:17582595.
44. Kunnumakkara, A.B., Anand, P., and Aggarwal, B.B. 2008. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 269: 199-225. doi:10.1016/j.canlet.2008.03.009. PMID:18479807.
45. Lee, C.S., Kwon, Y.W., Yang, H.M., Kim, S.H., Kim, T.Y., Hur, J., et al. 2009. New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9. Arterioscler. Thromb. Vasc. Biol. 29: 472-479. doi:10.1161/ATVBAHA.108.176230. PMID:19201691.
46. LeRoith, D., Werner, H., Beitner-Johnson, D., and Roberts, C.T., Jr. 1995. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 16: 143-163. doi:10.1210/edrv-16-2-143, 10.1210/er.16.2.143. PMID:7540132.
47. Li, Y., Zhang, J., Ma, D., Zhang, L., Si, M., Yin, H., and Li, J. 2012. Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling. FEBS J. 279: 2247-2259. doi:10.1111/j.1742-4658.2012.08607.x. PMID:22521131.
48. Lim, H.J., Park, H.Y., Ko, Y.G., Lee, S.H., Cho, S.Y., Lee, E.J., et al. 2004. Dominant negative insulin-like growth factor-1 receptor inhibits neointimal formation through suppression of vascular smooth muscle cell migration and proliferation, and induction of apoptosis 1. Biochem. Biophys. Res. Commun. 325: 1106-1114. doi:10.1016/j.bbrc.2004.10.175. PMID:15541402.
49. Liu, Y., Dolence, J., Ren, J., Rao, M., and Sreejayan, N. 2008. Inhibitory effect of dehydrozingerone on vascular smooth muscle cell function. J. Cardiovasc. Pharmacol. 52: 422-429. doi:10.1097/FJC.0b013e31818aed93. PMID:19033821.
50. Liu, G., Hitomi, H., Hosomi, N., Lei, B., Nakano, D., Deguchi, K., et al. 2011. Mechanical stretch augments insulin-induced vascular smooth muscle cell proliferation by insulin-like growth factor-1 receptor. Exp. Cell Res. 317: 2420-2428. doi:10.1016/j.yexcr.2011.07.016. PMID:21854769.
51. McCaffrey, T.A., Fu, C., Du, B., Eksinar, S., Kent, K.C., Bush, H., Jr., et al. 2000. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. J. Clin. Invest. 105: 653-662. doi:10.1172/JCI8592. PMID: 10712437.
52. Meng, D., Shi, X., Jiang, B.H., and Fang, J. 2007. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell prolifera-tion through reactive oxygen species. Free Radic. Biol. Med. 42: 1651-1660. doi:10.1016/j.freeradbiomed.2007.01.037. PMID:17462533.
53. Meng, D., Lv, D.D., and Fang, J. 2008. Insulin-like growth factor-I induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cells. Cardiovasc. Res. 80: 299-308. doi:10.1093/cvr/ cvn173. PMID:18567639.
54. Morimoto, T., Sunagawa, Y., Kawamura, T., Takaya, T., Wada, H., Nagasawa, A., et al. 2008. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J. Clin. Invest. 118: 868-878. PMID:18292809.
55. Nakmareong, S., Kukongviriyapan, U., Pakdeechote, P., Donpunha, W., Kukongviriyapan, V., Kongyingyoes, B., et al. 2011. Antioxidant and vascular protective effects of curcumin and tetrahydrocurcumin in rats with L-NAME-induced hypertension. Naunyn Schmiedebergs Arch. Pharmacol. 383: 519-529. doi:10.1007/s00210-011-0624-z. PMID:21448566.
56. Nguyen, T.T., Cao, N., Short, J.L., and White, P.J. 2006. Intravenous insulin-like growth factor-I receptor antisense treatment reduces angiotensin receptor expression and function in spontaneously hypertensive rats 1. J. Pharmacol. Exp. Ther. 318: 1171-1177. doi:10.1124/jpet.106.103655. PMID:16751253.
57. Pagel, J.I., and Deindl, E. 2011. Early growth response 1-a transcription factor in the crossfire of signal transduction cascades. Indian J. Biochem. Biophys. 48: 226-235. PMID:22053691.
58. Pagel, J.I., Ziegelhoeffer, T., Heil, M., Fischer, S., Fernandez, B., Schaper, W., et al. 2012. Role of early growth response 1 in arteriogenesis: impact on vascular cell proliferation and leukocyte recruitment in vivo. Thromb. Haemost. 107: 562-574. doi:10.1160/TH11-07-0490. PMID:22318678.
59. Park, K.W., Yang, H.M., Youn, S.W., Yang, H.J., Chae, I.H., Oh, B.H., et al. 2003. Constitutively active glycogen synthase kinase-3{beta} gene transfer sustains apoptosis, inhibits proliferation of vascular smooth muscle cells, and reduces neointima formation after balloon injury in rats. Arterioscler. Thromb. Vasc. Biol. 23: 1364-1369. doi:10.1161/01.ATV.0000081633.53390.B4. PMID: 12805073.
60. Patel, B.B., Gupta, D., Elliott, A.A., Sengupta, V., Yu, Y., and Majumdar, A.P. 2010. Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R. Anticancer Res. 30: 319-325. PMID:20332435.
61. Pendurthi, U.R., and Rao, L.V. 2000. Suppression of transcription factor Egr-1 by curcumin. Thromb. Res. 97: 179-189. doi:10.1016/S0049-3848(99)00148-6. PMID:10674404.
62. Ramirez-Bosca, A., Soler, A., Carrion, M.A., Diaz-Alperi, J., Bernd, A., Quintanilla, C., et al. 2000. An hydroalcoholic extract of Curcuma longa lowers the apo B/apo A ratio. Implications for atherogenesis prevention. Mech. Ageing Dev. 119: 41-47. doi:10.1016/S0047-6374(00)00169-X.
63. Reddy, A.C., and Lokesh, B.R. 1994. Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrous iron. Mol. Cell. Biochem. 137: 1-8. doi:10.1007/BF00926033. PMID: 7845373.
64. Ruiz-Torres, A., Lozano, R., Melon, J., and Carraro, R. 2003. L-calcium channel blockade induced by diltiazem inhibits proliferation, migration and F-actin membrane rearrangements in human vascular smooth muscle cells stimulated with insulin and IGF-1. Int. J. Clin. Pharmacol. Ther. 41: 386-391. PMID: 14518598.
65. Selvendiran, K., Kuppusamy, M.L., Bratasz, A., Tong, L., Rivera, B.K., Rink, C., et al. 2009. Inhibition of vascular smooth-muscle cell proliferation and arterial restenosis by HO-3867, a novel synthetic curcuminoid, through up-regulation of PTEN expression. J. Pharmacol. Exp. Ther. 329: 959-966. doi: 10.1124/jpet.108.150367. PMID:19276401.
66. Sreejayan, ••, and Rao, M.N. 1994. Curcuminoids as potent inhibitors of lipid peroxidation. J. Pharm. Pharmacol. 46: 1013-1016. doi:10.1111/j.2042-7158.1994. tb03258.x. PMID:7714712.
67. Stabile, E., Zhou, Y.F., Saji, M., Castagna, M., Shou, M., Kinnaird, T.D., et al. 2003. Akt controls vascular smooth muscle cell proliferation in vitro and in vivo by delaying G1/S exit. Circ. Res. 93: 1059-1065. doi:10.1161/01.RES.0000105086. 31909.1B. PMID:14605018.
68. Vardatsikos, G., and Srivastava, A.K. 2012. Involvement of Growth factor Receptor and Nonreceptor protein tyrosine kinases in endothelin-1 and angiotensin II-induced signaling pathways in the cardiocascular system. In Molecular defects in cardiovascular disease. Edited by N.R. Dhalla, M. Nagano, and B. Ostadal. Springer, New York, N.Y. pp. 315-333.
69. Vardatsikos, G., Sahu, A., and Srivastava, A.K. 2009. The insulin-like growth factor family: molecular mechanisms, redox regulation, and clinical implications. Antioxid. Redox Signal. 11: 1165-1190. doi:10.1089/ars.2008.2161. PMID:19014342.
70. Wilken, R., Veena, M.S., Wang, M.B., and Srivatsan, E.S. 2011. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol. Cancer, 10: 12. doi:10.1186/1476-4598-10-12. PMID:21299897.
71. Wu, X., Cheng, J., Li, P., Yang, M., Qiu, S., Liu, P., and Du, J. 2010. Mechanosensitive transcriptional factor Egr-1 regulates insulin-like growth factor-1 receptor expression and contributes to neointima formation in vein grafts. Arterioscler. Thromb. Vasc. Biol. 30: 471-476. doi:10.1161/ATVBAHA.109. 184259. PMID:19965784.
72. Xia, Y., Jin, L., Zhang, B., Xue, H., Li, Q., and Xu, Y. 2007. The potentiation of curcumin on insulin-like growth factor-1 action in MCF-7 human breast carcinoma cells. Life Sci. 80: 2161-2169. doi:10.1016/j.lfs.2007.04.008. PMID: 17499312.
73. Yang, H.M., Kim, H.S., Park, K.W., You, H.J., Jeon, S.I., Youn, S.W., et al. 2004. Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling. Circulation, 110: 301-308. doi:10.1161/01. CIR.0000135467.43430.16. PMID:15238462.
74. Yang, X., Thomas, D.P., Zhang, X., Culver, B.W., Alexander, B.M., Murdoch, W.J., et al. 2006. Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation. Arterioscler. Thromb. Vasc. Biol. 26: 85-90. doi:10.1161/01.ATV.0000191635. 00744.b6. PMID:16239599.
75. Zhang, W., Liu, D., Wo, X., Zhang, Y., Jin, M., and Ding, Z. 1999. Effects of Curcuma longa on proliferation of cultured bovine smooth muscle cells and on expression of low density lipoprotein receptor in cells. Chin. Med. J. (Engl.), 112: 308-311. PMID:11593527.